Methods for inducing orexin neurons and agent for treating narcolepsy or eating disorder
The invention provides a method for producing an orexin neuron by culturing a pluripotent stem cell or a neural progenitor cell in the presence of N-acetyl-D-mannosamine and optionally in the presence of at least one inhibitor selected from the group consisting of a Sirtuin 1 inhibitor and an O-linked β-N-acetylglucosamine transferase inhibitor. The invention also provides a therapeutic agent for narcolepsy or eating disorders, such as anorexia, containing N-acetyl-D-mannosamine, which is based on the induction of orexin neuron in vivo.
1. A method for inducing an orexin neuron, comprising a step of administering, as an active ingredient, an effective amount of N-acetyl-D-mannosamine to a subject in need thereof, or having, as an active ingredient, an effective amount of N-acetyl-D-mannosamine taken by a subject in need thereof, wherein the N-acetyl-D-mannosamine is selected from the group consisting of
salts thereof, whereby the orexin neuron is induced in the lateral hypothalamic area of the subject.
2. A method for treating narcolepsy or eating disorder based on induction of an orexin neuron in vivo, comprising a step of administering, as an active ingredient, an effective amount of N-acetyl-D-mannosamine to a subject in need thereof, wherein the N-acetyl-D-mannosamine is selected from the group consisting of 5S-ManNAcF, and salts thereof, whereby the orexin neuron is induced in the lateral hypothalamic area of the subject and the narcolepsy or the eating disorder is treated in the subject.
3. The method of claim 2 , wherein the narcolepsy is treated.
4. The method of claim 2 , wherein the eating disorder is treated.
5. The method of claim 4 , wherein the eating disorder is anorexia.
6. A method for inducing an orexin neuron, comprising a step of administering, as an active ingredient, an effective amount of N-acetyl-D-mannosamine to a subject in need thereof, or having, as an active ingredient, an effective amount of N-acetyl-D-mannosamine taken by a subject in need thereof, wherein the N-acetyl-D-mannosamine is selected from the group consisting of 5S-ManNAcF, and salts thereof, whereby the orexin neuron is induced in the lateral hypothalamic area of the subject.
7. The method of claim 1 , wherein the N-acetyl-D-mannosamine is ManNAcF or a salt thereof.
8. The method of claim 1 , wherein the N-acetyl-D-mannosamine is ManNCOOMe or a salt thereof.
9. The method of claim 1 , wherein the N-acetyl-D-mannosamine is ManNCOOEt or a salt thereof.